Ethics notification for the structured retrospective recording of quality assurance measures of cutaneous perfusion and oxygenation using a hyperspectral camera in the intensive care unit

• Conditions: A41; Other sepsis

• Registration Number: DRKS00030877
• Lead Sponsor: niversitätsmedizin Mainz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-01-10
• Study Completion: 2023-08-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age at least 18 years
intensive care patients
PiCCO and/or PA catheters and/or cerebral NIRS
ECCMO therapy
sepsis or condition cardiac surgery

Exclusion Criteria

Severe peripheral arterial disease
Age <18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective is the retrospective recording of the different hemodynamic factors influencing hyperspectral imaging.

Secondary Outcome Measures

Name	Time	Method
A secondary objective is to assess the influence of necessary measures such as the administration of large amounts of liquid, transfusions, catecholamines and ECMO settings on hyperspectral imaging.